Travere Therapeutics (TVTX) Net Margin Growth (1y) (2015 - 2025)
Travere Therapeutics (TVTX) Net Margin Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -701.00 |
| Dec 31, 2024 | 348.00 |
| Sep 30, 2024 | -64,702.00 |
| Jun 30, 2024 | -5,203.00 |
| Mar 31, 2024 | -3,338.00 |
| Dec 31, 2023 | -7,103.00 |
| Sep 30, 2023 | 59,561.00 |
| Jun 30, 2023 | 526.00 |
| Mar 31, 2023 | 846.00 |
| Dec 31, 2022 | 1,143.00 |
| Sep 30, 2022 | 10,356.00 |
| Jun 30, 2022 | 11,680.00 |
| Mar 31, 2022 | 13,829.00 |
| Dec 31, 2021 | 29,465.00 |
| Sep 30, 2021 | -815.00 |
| Jun 30, 2021 | -1,760.00 |
| Mar 31, 2021 | -11,537.00 |
| Dec 31, 2020 | -17,374.00 |
| Sep 30, 2020 | 3,814.00 |
| Jun 30, 2020 | 3,274.00 |